Hong Kong stock market activity | Hanson Pharmaceuticals (03692.HK) rises more than 4% to achieve global exclusive license agreement on IL-23 with Avere Avere to be merged into NextCure

Wisdom Finance APP learned that Hansen Pharmaceutical (03692.HK) rose by more than 4%, as of the time of publication, it increased by 3.93% and closed at 33.84 Hong Kong dollars, with a turnover of 285 million Hong Kong dollars.